Major projects with published output accessible online, in order of the most recent (see end for freelance news coverage)
Parent Project Muscular Dystrophy
Medical writer:
Submission of a Proposed Draft Guidance for Industry on Developing Drugs for Treatment of Duchenne Muscular Dystrophy; Establishment of a Public Docket (see here)
Cover letter for submission:
The Draft Guidance for Industry on Developing Drugs for the Treatment of Duchenne Muscular Dystrophy (see here)
Accolades and media coverage of the Draft Guidance:
Wall Street Journal: A Patients’ Group Scores a Win in Muscular Dystrophy Drug Research
Market Watch: First-Ever Patient-Initiated “Guidance for Industry” for Duchenne Muscular Dystrophy Submitted to FDA
Rare Disease Report: FDA Opens PPMD’s Draft Guidance For Managing Duchenne to the Public Discussion
Regulatory Society Professionals Society: FDA Wants Input on Patient-Developed DMD Guidance
GNP+/The International HIV/AIDS Alliance/STOP AIDS NOW!
Co-authored (with Aditi Sharma):
Driving the HIV Response. A Community Guide to the WHO 2013 ART Guidelines (see here)
Related/promotion: (see here)
The British Columbia Centre for Excellence in HIV/AIDS
Speaker on Treatment as Prevention’s Impact on TB
And on WHO’s Revised 2013 ART Guidelines
World Health Organization, HIV and Global TB Departments
Consultant, rapporteur/writer of the following:
WHO Three ‘I’s meeting: intensified case finding, isoniazid preventive therapy and TB infection control for people living with HIV (see here)
Catalysing HIV/TB research: a meeting report (see here)
Measures to reduce the burden of TB and HIV in injecting and other drug users project (see here)
Collaborative TB and HIV services for drug users (see here)
Integrated TB/HIV and other health services for people who use drugs (see here)
HIV and TB in Practice in India: Integrating TB/HIV care and other essential health services into ‘targeted interventions’ for drug users (see here)
WHO funded booklets:
Think TB in People with HIV (see here)
Caring for the Caregivers in the Face of HIV and TB (see here)
Special HATIPs:
ART and TB prevention (see here)
TB-HIV news from the 44th Union World Conference on Lung Health (see here)
Clinical Care Options
Coordinating editor for the entire resource InPractice Africa (and wrote many of the 25 early draft chapters on HIV and TB)
The Global Network of People Living with HIV (GNP+
Consultant/rapporteur/writer:
HIV Leadership Through Accountability Planning & Review Meeting of Networks of People Living with HIV and Civil Society Partners (see here)
PLHIV Input into the Revision of the WHO ART Guidelines Final Report of GNP+ Consultations: Technical consultation at IAS 2009, Cape Town, Technical consultation at ICAAP 2009, Bali, E-consultation (see here)
Positive Health, Dignity and Prevention in Nigeria: Findings and Recommendations from Studies Led by People Living with HIV (see here)
Positive Health, Dignity and Prevention in Kenya: Findings and Recommendations from Studies Led by People Living with HIV (see here)
Most of the program new stories on the HIV Leadership Through Accountability website (to help document participants progress for program’s M&E framework):
NAM Publications: www.aidsmap.com/HATIP
Editor/writer
Writer of about 200 HATIPs, starting in 2003:
Palliative care and home-based care for HIV (see here)
Learning from Botswana (see here)
Main article: Delivering 3 X 5: what are the next steps? (see here) (Co-authored)
South Africa’s national treatment programme (see here)
Isoniazid prophylaxis treatment for children with HIV: is it ready for implementation? (see here)
Rethinking nevirapine revisited (see here)
Immune reconstitution inflammatory syndrome (IRIS) in the developing world (see here)
An integrated approach to HIV and TB care in adults in resource-limited settings, part 1 (see here)
HIVNET 012 controversy puts ART programmes at risk (see here)
[Accolades for this piece: http://www.tac.org.za/news/anc-today-article-inaccurate-and-contradicts-anc-and-government-policy]
HIV’s impact on TB control: is it time to re-think TB control strategies? (see here)
Children with HIV are being left behind in the rollout of antiretroviral therapy (see here)
Improving access to appropriate paediatric antiretroviral formulations (see here)
Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated (see here)
HIV and malnutrition (see here)
Barriers to ART scale up, and potential solutions (see here)
HAART and harvest: antiretroviral therapy and nutrition when food is scarce (see here)
South African progress report on scale up of HIV treatment and care (see here)
Safer infant feeding (see here)
HIV treatment activism moves into the TB field (see here)
WHO calls for an end to the marketing of sub-optimal malaria treatments (see here)
HIV and malaria: when elephants collide (see here)
Management of HIV and hepatitis B or C co-infection in resource-limited settings (see here)
Expanding beyond DOTS to stop TB (see here)
Integrating prevention research into the provision of HIV care (see here)
Monitoring antiretroviral treatment with limited laboratory services (see here)
Getting the most prevention and care out of programmes for the prevention of mother-to-child transmission (see here)
HIV treatment for mothers and children in Botswana: lessons from a dynamic programme (see here)
Lowering the threshold — Is there a case for re-evaluating eligibility criteria for ART? (see here)
Scaling up laboratory capacity for the coming storm of XDR-TB, and why the HIV treating community must get involved now (see here)
TB transmission in healthcare settings and improving infection control (see here)
Neuro AIDS (see here)
Patient retention challenges and the need for more active follow-up (see here)
Making the world safe for more routine HIV testing (see here)
HIV treatment and displaced populations (see here)
It’s time to integrate TB/HIV care on a national scale (see here)
Towards a comprehensive package of preventive and palliative care (see here)
Palliative care: pain and symptom control being ignored in South Africa due to lack of training, legal barriers (see here)
Defining, and then watching for, treatment failure (see here)
Time for clear and simple messages about delivering isoniazid preventive therapy (IPT) (see here)
Managing meningitis in people with HIV in resource-limited settings: a clinical review (see here)
Early Infant Diagnosis (see here)
Kaposi’s sarcoma: a clinical review (see here)
Think TB in people with HIV: start routinely screening for TB now (see here)
Intensified case finding: developing an action plan (see here)
The management of childhood pneumonia in settings with a high burden of HIV (see here)
Our health facilities are still unsafe: why we all need to do something about TB infection control (see here)
Three I’s to reduce the burden of TB in people with HIV (see here)
Task Shifting (see here)
Improving human resources for health while scaling up ARV access in Ethiopia and Malawi (see here)
Childhood TB, Pt 1, Pt 2, Pt 3
TB Research is Research to Save the Lives of People with HIV (see here)
Peripheral Neuropathy in People with HIV in Resource-Limited Settings (see here)
Appropriate prevention and care services for men who have sex with men and transgender people in resource-limited settings (see here)
Experts at 2009 HIV Implementers’ meeting worry about sustainability of HIV programmes (see here)
Nutrition in ART Programmes (etc…) (see here)
Provision of TB/HIV services in Asia-Pacific countries with a heavy burden of TB and concentrated HIV epidemics (see here)
Mental health and HIV: a clinical review (see here)
After my parents died: The effect of HIV on the mental health of children: a clinical review (etc…) (see here)
DetecTB study shows intensified case finding can reduce burden of TB within community with high HIV prevalence (see here)
TB/HIV treatment literacy (see here)
Integrating TB and HIV services: lessons from the field (see here)
Diarrhoea in children with HIV: a clinical review (see here)
Towards more compassionate care for people with drug-resistant TB (see here)
Managing MDR-TB in the community: from presentation to cure or end-of-life care (see here)
Bridging the divide: HIV and health systems (see here)
New joint guidelines on IPT and intensified case-finding from WHO (see here)
Kidney Disease in people living with HIV, pt 1
Adherence and retention in HIV care in resource-limited settings (see here)
South Africa AIDS Conference: Special Issue (see here)
What will it take to put millions more South Africans onto antiretroviral therapy? (see here)
Can integration of HIV with other health services strengthen the health response? (see here)
HIV and non-communicable diseases (NCDs) (see here)
An intensive household counselling intervention reduces the burden of TB in ZAMSTAR study (see here)
Strengthening labs and introducing new tools for increased case detection and earlier diagnosis of TB (see here)
HIV and TB in Practice for nurses (first issue, see HATIP for others)
TB, HIV, mothers and children: time for action (see here)
Diagnosing and preventing TB in children (see here)
Strengthening TB laboratory capacity to support active case finding (see here)
HIV and TB in Practice: Moving towards combination TB prevention (see here)
Point-of-care (POC) diagnostics are essential to achieving an AIDS-free generation and improving outcomes in HIV-exposed children (see here)
Have written many other articles and covered many conferences for www.aidsmap.com
One highly praised series: the coverage of the Microbicides Conference in Cape Town, 2006
Microbicides 2006: what products are in the pipeline? (see here)
Microbicides 2006: Who will control microbicides? (see here)
Microbicides 2006: Poor adherence reported in some of the microbicide studies (see here)
Microbicides 2006: Microbicide efficacy studies target high risk women for enrolment (see here)
Are the microbicide clinical efficacy studies big enough? (see here)
Microbicides 2006: High rates of pregnancy pose challenges for microbicide trials (see here)
Microbicides 2006 meeting opens with a focus on the women of Africa and the failure of existing HIV prevention methods (see here)
Microbicides 2006: Treatment Action campaign marches for HIV prevention (see here)
High concentrations of lime juice kill HIV but too caustic to use as a microbicide (see here)
Microbicides 2006: High concentrations of lime juice kill HIV but too caustic to use as a microbicide (see here)
Microbicide activity against sexually transmitted infections could affect how good products look against HIV (see here)
ACTAVIS Group for AIDSTAR-One/USAID & John Snow, Inc.: March-August 2010
Writer (developed and/or updated technical resource pages on biomedical HIV prevention interventions for a web-based HIV-knowledge hub website: (note — these have since been updated by other writers, but the format is the same)
The Consortium to Respond Effectively to the AIDS TB Epidemic (CREATE)
Writer/rapporteur
“Engaging Community in Tuberculosis Research” (see here)
The 3 I’s Satellite Symposium: Reducing the Risk of Tuberculosis in HIV-infected Individuals (see here)
Diana, Princess of Wales Memorial Fund May-July 2012
How HIV care promotes prevention in Where’s the Care? Enhancing adherence, retention, and quality of life in people living with HIV (see here)
Examples of recent freelance articles
The Body Pro:
http://www.thebodypro.com/content/75212/hiv-researchers-weigh-in-on-ebola-outbreak.html
http://www.thebodypro.com/content/75026/for-hivhcv-coinfected-patients-3d-with-ribavirin-h.html
http://www.thebodypro.com/content/75229/what-2014-development-has-the-biggest-impact-on-hi.html
http://www.thebodypro.com/content/75130/preventing-and-treating-hiv-associated-bone-diseas.html
http://www.thebodypro.com/content/75244/cardiovascular-complications-in-patients-living-wi.html
http://www.thebodypro.com/content/75239/what-does-2015-hold-in-store-for-hiv-research.html
http://www.thebodypro.com/content/74975/copd-may-be-common-and-underdiagnosed-in-people-li.html
http://www.thebodypro.com/content/75207/starting-hiv-treatment-responses-compared-in-older.html
http://www.thebodypro.com/content/75236/what-do-hiv-clinicians-tell-their-patients-about-p.html
Recognition: see Briefly: Heart disease missed; HAART and aging
http://www.positivelyaware.com/articles/january-2015-briefly
HIVandHepatitis.com:
Global Health Strategies
Wrote a report on Ebola Research and Development,
Partially unpublished but some supported work on the treatmentsciencewriters.com blog site
Examples:
http://treatmentsciencewriters.com/news/lessons-learned-hot-zone/
http://treatmentsciencewriters.com/news/ebolas-impact-west-african-countries-health-infrastructure/
http://treatmentsciencewriters.com/news/coordination-new-teams-ebola-responders-big-challenge/
http://treatmentsciencewriters.com/news/coordination-new-teams-ebola-responders-big-challenge/
http://treatmentsciencewriters.com/news/black-market-ebola-convalescent-blood-products/
http://treatmentsciencewriters.com/news/ebola-outbreak-large/
Work from before 2003
TAG
Co-author:
Problems with Protease Inhibitor Development Plans (see here)
New Drug Dilemma’s: Scientific and Regulatory Issues in the Era of Antiretroviral Polytherapy and a Viral Load-Driven Standard of Care. A Report to the FDA Antiviral Drugs Advisory Committee (see here)
The antiviral report: a critical view of new antiretroviral drugs and treatment strategies veriso 1.0, June 1998 (see here)
GMHC
Writer/Editor for Treatment Issues
Viral Resistance to Protease Inhibitors (see here)
1995: International Congress of Chemotherapy (see here)
Variations in Viral Load Still Under Investigation (see here)
1996: Making Inroads on PML (see here)
1996: Free Introductory offer on Viral Load Tests here)
Physician Research Network
Editor/writer of the PRN Notebook
First three issues: (available for purchase)
Common Cutaneous Complications of HIV Disease (see here)
Minding the Gaps: The Forum for Collaborative HIV Research (FCHR) (Co-authored) (see here)